Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation

被引:72
|
作者
Clarkesmith, Danielle E. [1 ]
Pattison, Helen M. [2 ]
Khaing, Phyo H. [3 ]
Lane, Deirdre A. [1 ]
机构
[1] Univ Birmingham, Inst Cardiovasc Sci, City Hosp, Sandwell & West Birmingham Hosp NHS Trust, Dudley Rd, Birmingham B18 7QH, W Midlands, England
[2] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England
[3] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England
关键词
International Normalized Ratio [standards; Patient Education as Topic; Administration; Oral; Anticoagulants [administration & dosage; adverse effects; Atrial Fibrillation [blood; complications; Chronic Disease; Decision Support Techniques; Drug Monitoring [methods; standards; Medication Adherence; Randomized Controlled Trials as Topic; Self Care [methods; Stroke [blood; etiology; prevention & control; Aged; Humans; Middle Aged; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; INTERNATIONAL NORMALIZED RATIO; COMPUTERIZED DECISION-SUPPORT; HEART RHYTHM ASSOCIATION; SELF-MANAGEMENT PROGRAM; VS. USUAL CARE; ORAL ANTICOAGULATION; WARFARIN THERAPY; ANTITHROMBOTIC THERAPY;
D O I
10.1002/14651858.CD008600.pub3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Current guidelines recommend oral anticoagulation therapy for patients with atrial fibrillation (AF) with one or more risk factors for stroke; however, anticoagulation control (time in therapeutic range (TTR)) with vitamin K antagonists (VKAs) is dependent on many factors. Educational and behavioural interventions may impact patients' ability to maintain their international normalised ratio (INR) control. This is an updated version of the original review first published in 2013. Objectives To evaluate the effects of educational and behavioural interventions for oral anticoagulation therapy (OAT) on TTR in patients with AF. Search methods We updated searches from the previous review by searching the Cochrane Central Register of Controlled Trials (CENTRAL) and the Database of Abstracts of Reviews of Effects (DARE) in The Cochrane Library (January 2016, Issue 1), MEDLINE Ovid (1949 to February week 1 2016), EMBASE Classic + EMBASE Ovid (1980 toWeek 7 2016), PsycINFO Ovid (1806 toWeek 1 February 2016) and CINAHL Plus with Full Text EBSCO (1937 to 16/02/2016). We applied no language restrictions. Selection criteria We included randomised controlled trials evaluating the effect of any educational and behavioural intervention compared with usual care, no intervention, or intervention in combination with other self-management techniques among adults with AF who were eligible for, or currently receiving, OAT. Data collection and analysis Two of the review authors independently selected studies and extracted data. Risk of bias was assessed using the Cochrane 'Risk of bias' tool. We included outcome data on TTR, decision conflict (patient's uncertainty in making health-related decisions), percentage of INRs in the therapeutic range, major bleeding, stroke and thromboembolic events, patient knowledge, patient satisfaction, quality of life (QoL), beliefs about medication, illness perceptions, and anxiety and depression. We pooled data for three outcomes - TTR,anxiety and depression, and decision conflict - and reported mean differences ( MD). Where insufficient data were present to conduct a meta-analysis, we reported effect sizes and confidence intervals (CI) from the included studies. We evaluated the quality of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Main results Eleven trials with a total of 2246 AF patients (ranging from 14 to 712 by study) were included within the review. Studies included education, decision aids, and self-monitoring plus education interventions. The effect of self-monitoring plus education on TTR was uncertain compared with usual care (MD 6.31, 95% CI -5.63 to 18.25, I-2 = 0%, 2 trials, 69 participants, very low-quality evidence). We found small but positive effects of education on anxiety (MD -0.62, 95% CI -1.21 to -0.04, I-2 = 0%, 2 trials, 587 participants, low-quality evidence) and depression (MD -0.74, 95% CI -1.34 to -0.14, I-2 = 0%, 2 trials, 587 participants, low-quality evidence) compared with usual care. The effect of decision aids on decision conflict favoured usual care (MD -0.1, 95% CI -0.17 to -0.02, I-2 = 0%, 2 trials, 721 participants, low-quality evidence). Authors' conclusions This review demonstrates that there is insufficient evidence to draw definitive conclusions regarding the impact of educational or behavioural interventions on TTR in AF patients receiving OAT. Thus, more trials are needed to examine the impact of interventions on anticoagulation control in AF patients and the mechanisms by which they are successful. It is also important to explore the psychological implications for patients suffering from this long-term chronic condition.
引用
收藏
页数:82
相关论文
共 50 条
  • [1] Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation
    Clarkesmith, Danielle E.
    Pattison, Helen M.
    Lane, Deirdre A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
  • [2] ANTICOAGULANT THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
    Belenkov, Yu. N.
    Shakaryants, G. A.
    Khabarova, N., V
    An, G., V
    KARDIOLOGIYA, 2018, 58 (10) : 45 - 52
  • [3] Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
    Hori, Hiroshi
    Fukuchi, Takahiko
    Sugawara, Hitoshi
    INTERNAL MEDICINE, 2021, 60 (04) : 495 - 506
  • [4] Individualising Anticoagulant Therapy in Atrial Fibrillation Patients
    Alings, Marco
    ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2016, 5 (02) : 102 - 109
  • [5] Anticoagulant therapy in atrial fibrillation
    Gandjbakhch, E.
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (08): : 854 - 862
  • [6] ANTICOAGULANT THERAPY IN ATRIAL FIBRILLATION
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1963, (536): : 984 - +
  • [7] Atrial fibrillation and anticoagulant therapy
    Salas, J
    López, A
    Zambrana, JL
    Díez, F
    MEDICINA CLINICA, 1999, 113 (10): : 397 - 397
  • [8] Combined aspirin and anticoagulant therapy in patients with atrial fibrillation
    So, Charlotte H.
    Eckman, Mark H.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (01) : 7 - 17
  • [9] Bleeding Complications in Atrial Fibrillation Patients on Anticoagulant Therapy
    Silvastru , Ionela
    Keresztesi, Gabriela
    Keresztesi, Arthur Atilla
    Cozlea, Daniel Laurentiu
    Caldararu, Carmen
    Dobru, Daniela Ecaterina
    REVISTA DE CHIMIE, 2019, 70 (05): : 1582 - 1585
  • [10] Anticoagulant Therapy in Connection With Cardioversion in Patients With Atrial Fibrillation
    Furman, N. V.
    Kuvshinova, L. E.
    Dovgalevsky, Ya P.
    KARDIOLOGIYA, 2012, 52 (09) : 69 - 76